Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
EVG.L Share News (EVG)
EVG Share
Price
EVG Share
News
EVG Share
Chat
EVG Share
Trades
EVG
Live RNS
EVG Share
Charts
EVG Broker
Ratings
EVG Directors
Deals
EVG Financial
Diary
EVG
Fundamentals
EVG Short
Positions
EVG
Media
EVG Company
Research
EVG Company
Timeline
- There is currently no data for EVG
Evolution ponders Panmure bid
Latest EVG News
- Friday broker round-up
27 Jul 2018 - Evgen Pharma Expects Final Results From Clinical Trials At End Of Year
26 Jul 2018 - Evgen concludes patient recruitment in STEM breast cancer trial
25 Jul 2018 - Wednesday broker round-up
25 Jul 2018 - Evgen Pharma Metastatic Breast Cancer Trial Ends Patient Recruitment
25 Jul 2018 - UK Shareholder Meetings Calendar - Next 7 Days
19 Jul 2018 - Evgen Pharma Annual Loss Narrows As It Continues Phase II Trials
13 Jun 2018 - Evgen STEM Interim Trial Result Show "Signs Of Anti-Tumour Activity"
11 Jun 2018
Related News
TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
TRADING UPDATES: Northcoders launches bootcamp; Schroder invests
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...
EVG.L News
Friday broker round-up
(Sharecast News) - William Hill: Peel Hunt upgrades to hold with a target price of 305p.
Evgen Pharma Expects Final Results From Clinical Trials At End Of Year
LONDON (Alliance News) - Evgen Pharma PLC said Thursday it expects to receive the final read-out from two clinical trials by the end of 2018.The drug ...
Evgen concludes patient recruitment in STEM breast cancer trial
(Sharecast News) - Clinical-stage drug development company Evgen Pharma has concluded patient recruitment in its STEM Phase IIa trial of SFX-01 in met...
Wednesday broker round-up
(Sharecast News) - Unite Group: Numis downgrades to hold with a target price of 900p.
Evgen Pharma Metastatic Breast Cancer Trial Ends Patient Recruitment
LONDON (Alliance News) - Evgen Pharma PLC said Wednesday it has concluded its patient recruitment for its STEM Phase IIa trial of SFX-01 in metastatic...
UK Shareholder Meetings Calendar - Next 7 Days
Friday 20 JulyHomeserveKCOM GroupMonday 23 JulyEthernity Energy 24
Evgen Pharma Annual Loss Narrows As It Continues Phase II Trials
LONDON (Alliance News) - Clinical drug development company Evgen Pharma PLC said Wednesday its annual loss narrowed in line with expectations.Evgen, w...
Evgen STEM Interim Trial Result Show "Signs Of Anti-Tumour Activity"
LONDON (Alliance News) - Evgen Pharma PLC said Monday its STEM trial showed "early signs of anti-tumour activity" in breast cancer patients.STEM is th...
Follow the stocks
